Scholar Rock (SRRK)
Develops anti-myostatin antibodies for spinal muscular atrophy and other neuromuscular diseases.
$51.00
After hours−0.20 (−0.39%)
At close$51.20(+6.31%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
in 52 days
EPS estimate
−$0.86
Revenue estimate
$732.5K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.60−$0.67−$0.98−$0.90−$0.88−$0.83−$0.84Pending
Estimate−$0.60−$0.63−$0.66−$0.84−$0.88−$0.82−$0.84−$0.86
Surprise0.0%−6.3%−48.5%−7.8%+0.3%−1.2%+0.1%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——————$0Pending
Estimate——$55.6K$50.0K$1.8M$5.0M$70.0K$732.5K
Surprise——————−100.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.09 | — | — |
| Sep 2028 | −$0.25 | — | — |
| Jun 2028 | −$0.37 | — | — |
| Mar 2028 | −$0.48 | — | — |
| Dec 2027 | −$0.44 | — | — |
| Sep 2027 | −$0.57 | — | — |
| Jun 2027 | −$0.68 | — | — |
| Mar 2027 | −$0.72 | — | — |
| Dec 2026 | −$0.81 | — | — |
| Nov 2026 | −$0.86 | — | — |
| Aug 2026 | −$0.84 | −$0.84 | +0.1% |
| May 2026 | −$0.82 | −$0.83 | −1.2% |
| Mar 2026 | −$0.88 | −$0.88 | +0.3% |
| Nov 2025 | −$0.84 | −$0.90 | −7.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Mar 2018 | |||
| May 2018 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.09 | — | — | $145.5M | — | — | — |
| Sep 2028 | −$0.25 | — | — | $117.2M | — | — | — |
| Jun 2028 | −$0.37 | — | — | $92.5M | — | — | — |
| Mar 2028 | −$0.48 | — | — | $71.5M | — | — | — |
| Dec 2027 | −$0.44 | — | — | $53.1M | — | — | — |
| Sep 2027 | −$0.57 | — | — | $42.8M | — | — | — |
| Jun 2027 | −$0.68 | — | — | $24.9M | — | — | — |
| Mar 2027 | −$0.72 | — | — | $13.6M | — | — | — |
| Dec 2026 | −$0.81 | — | — | $5.9M | — | — | — |
| Nov 13, 2026 | −$0.86 | — | — | $732.5K | — | — | — |
| Aug 6, 2026 | −$0.84 | −$0.84 | +0.1% | $70.0K | $0 | −100.0% | +10.0% |
| May 7, 2026 | −$0.82 | −$0.83 | −1.2% | $5.0M | — | — | −1.4% |
| Mar 3, 2026 | −$0.88 | −$0.88 | +0.3% | $1.8M | — | — | +1.9% |
| Nov 14, 2025 | −$0.84 | −$0.90 | −7.8% | $50.0K | — | — | +24.4% |
| Aug 6, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 7, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| Mar 31, 2018 | |||||||
| May 24, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |